Redefining Peripheral Artery Disease diagnosis

Doppler ultrasound, the primary screening test for PAD, requires a high level of skill for accurate results.  Clinicians need a fast, simple, accurate, easy to use PAD screening test that can be performed by any healthcare provider. Our pioneering, autonomous, hands-free ultrasound technology, guided by advanced AI is easier to use, more accurate, and enables early detection and better patient outcomes.

Peripheral Artery Disease

PAD is the 2nd leading cause of morbidity and mortality in the western world, and its prevalence is expected to rise to 19 Million Americans by 2050.  Early, accurate detection is key to improving patient outcomes.

12 million patients impacted

60% have Coronary Artery Disease (CAD)

11% have Chronic Limb Threatening

$250B annual economic burden

Disruptive ultrasound innovation

Fast, accurate, easy-to-use PAD diagnostic system

Our multi-element, hands-free, automated vessel location system improves the speed and accuracy of doppler ultrasound procedures and offers greater patient comfort.   The rapid-fire ultrasound signals accurately locate the desired vessels, regardless of patient size or body type.  Our one-of-a-kind stochastic resonance technology boosts weak signals to give reliable results even in low flow states.  These improved signals are analyzed by our advanced AI algorithms provide a clear, easy-to-understand diagnostic report and deliver the most reliable, accurate PAD diagnosis available today.

 

UltraSense hears what others can not.

Subscribe to our newsletter “CorRen Chronicles” for the latest news

Our Partners

Partner:  BETA MN
Partner:  MN Cup
Partner:  MN DEED
Partner:  University of MN<br />
Partner: University of MS Medical Center
Partner:  University Health